NORTHERN TRUST CORP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$41,417
+64.2%
11,5690.0%0.00%
Q1 2023$25,221
-82.3%
11,569
-2.2%
0.00%
Q4 2022$142,339
+58.2%
11,832
-15.0%
0.00%
Q3 2022$90,000
+45.2%
13,925
+2.1%
0.00%
Q2 2022$62,000
-97.5%
13,640
-95.2%
0.00%
Q1 2022$2,443,000
-29.6%
282,378
+16.1%
0.00%
-100.0%
Q4 2021$3,472,000
-30.1%
243,125
+7.7%
0.00%0.0%
Q3 2021$4,964,000
+75.8%
225,831
+7.0%
0.00%
Q2 2021$2,824,000
+5034.5%
211,082
+1055.4%
0.00%
Q4 2018$55,000
-37.5%
18,269
+1.4%
0.00%
Q3 2018$88,00018,0100.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders